The adenoma detection rate of standard non-AI-assisted colonoscopy was significantly lower after exposure to AI.

In 2024, 43% of patients reported their symptoms were currently very or extremely bothersome vs 62% in 2015, but 76% still found it somewhat or very difficult to manage their symptoms. HealthDay News ...

Anti-TNFs were durable for 3 years among over 75% of children with Crohn disease, but durability was lower for children with ulcerative colitis or IBD-unclassified.

Exercise in addition to colon cancer treatment has been used to manage physical functioning and research shows help with improving survival.

Kerendia (finerenone) Nonsteroidal mineralocorticoid receptor antagonist. To reduce the risk of cardiovascular death, hospitalization for heart failure (HF), and urgent HF visits in adult patients ...

Patients on the highest dose of oral pill orforglipron lost an average 27.3 pounds, or 12.4% of their body weight, over 72 weeks. HealthDay News — A new weight loss pill made by Eli Lilly helped ...

Dr Vinay Prasad will return to direct the FDA’s Center for Biologics Evaluation and Research after being removed July 29.

The table below is a review of notable updates that occurred in July 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Compared with cisgender heterosexual individuals, sexual gender minority individuals may experience more severe symptoms of IBS and more psychological distress.

HealthDay News — Among adults aged 45 to 49 years, local colorectal cancer (CRC) incidence increased from 2019 to 2022 and CRC screening increased from 2019 to 2023, according to two studies published ...

A number of young adults and adolescents who are eligible for GLP-1 receptor agonists were not currently insured.

Higher intakes of potatoes were associated with an increased risk for T2D after adjustment for diabetes-related risk factors.